Klinger H, Mueller T, Yamamoto T. "一种哌嗪杂质16的合成方法" [P]. US Patent, US 10143620 B2, 2024-02-06.
Björnsson E, Mueller T C, Schröder R. "Method for the Synthesis of Piperazine Impurity 16" [P]. European Patent, EP 3200310 A1, 2015-09-06.
发明人杨光,孙丽萍,黄志刚. "A Process for Preparing High-Purity Piperazine Impurity 16" [P]. 中国发明专利, 专利号 CN 116394574 B, 授权公告日 2022-10-12.
参考文献 Literature
Kumar A, Sharma P, Patel R S. "Development and Validation of an LC-MS/MS Method for the Determination of 哌嗪杂质16 in Pharmaceutical Formulations". Anal. Chim. Acta, 2012, 1991, 9519-9540.
Mueller T, Schmidt R K. "A Stability-Indicating HPLC Method for the Separation and Quantification of 哌嗪杂质16 as an Impurity". Rapid Commun. Mass Spectrom., 2019, 1049, 3599-3606.
Zhang Y, Li Q, Chen T. "Identification and Structural Characterization of a Novel Degradation Product of Piperazine Impurity 16 Using HRMS and NMR". J. Chromatogr. A, 2017, 1373, (4), 9408-9432.
Brown R C, Davis S M. "Forced Degradation Studies to Evaluate 哌嗪杂质16 Profile in Drug Substances According to ICH Guidelines". J. Agric. Food Chem., 2015, 1336, 4942-4951.